Blood Galectin-3 Levels Predict Postoperative Complications after Colorectal Cancer Surgery

J Nippon Med Sch. 2019;86(3):142-148. doi: 10.1272/jnms.JNMS.2019_86-302.

Abstract

Background: Recent studies suggested that galectin-3 may act as a pro-inflammatory damage-associated molecular pattern. The aim of this study is to investigate the association between blood galectin-3 and postoperative complications (POC) after colorectal cancer (CRC) surgery.

Methods: Blood samples were taken from 35 patients with CRC before surgery, immediately after surgery, and on postoperative days (POD) 1, 3, 5, and 7. Blood galectin-3 and interleukin-6 levels were measured by commercially available ELISA. Patients were divided into those with (POC group) and without POC (no-POC group).

Results: Significantly higher galectin-3 levels were observed pre- and postoperatively in the POC group (n=10) compared with those of the no-POC group (n=25). Galectin-3 levels on POD1 showed the best predictive potential for POC (cut-off: 3.18 pg/mL, area under the curve: 0.868).

Conclusions: These results indicate that increased perioperative blood galectin-3 levels may be associated with POC after CRC surgery.

Keywords: colorectal cancer; galectin-3; postoperative complication; surgery.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Colorectal Neoplasms / surgery*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Galectin 3 / blood*
  • Humans
  • Inflammation Mediators / blood
  • Interleukin-6 / blood
  • Male
  • Postoperative Complications / diagnosis*
  • Predictive Value of Tests
  • Time Factors

Substances

  • Biomarkers
  • Galectin 3
  • Inflammation Mediators
  • Interleukin-6